Barrett & Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Hold
1,179
0.01% 439
2026
Q1
$15.9K Buy
1,179
+1
+0.1% +$14 0.01% 427
2025
Q4
$14.7K Hold
1,178
﹤0.01% 436
2025
Q3
$11.7K Hold
1,178
﹤0.01% 455
2025
Q2
$10.5K Sell
1,178
-5
-0.4% -$42 ﹤0.01% 467
2025
Q1
$10.3K Buy
1,183
+11
+0.9% +$115 ﹤0.01% 438
2024
Q4
$14.6K Hold
1,172
0.01% 404
2024
Q3
$13.6K Sell
1,172
-7
-0.6% -$81 0.01% 403
2024
Q2
$12.5K Hold
1,179
0.01% 416
2024
Q1
$14.1K Buy
1,179
+1
+0.1% +$12 0.01% 404
2023
Q4
$12.8K Sell
1,178
-24
-2% -$230 0.01% 392
2023
Q3
$11.9K Sell
1,202
-468
-28% -$4.87K 0.01% 399
2023
Q2
$16.6K Sell
1,670
-51
-3% -$487 0.01% 373
2023
Q1
$16.6K Buy
1,721
+58
+3% +$643 0.01% 346
2022
Q4
$18.5K Hold
1,663
0.01% 326
2022
Q3
$18.5K Buy
+1,663
New +$16.4K 0.01% 326

Other funds holding VTRS

Barrett & Company's VTRS Position: Q2 2026 in Review

Barrett & Company held its Viatris (VTRS) position steady in Q2 2026 at 1,179 shares worth $18.7K. The position accounts for 0.01% of the portfolio, ranked #439.

Barrett & Company first reported a position in VTRS in Q3 2022 and has held it in 16 quarters since. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Barrett & Company held 1,179 shares of Viatris worth $18.7K as of Q2 2026.
  • Barrett & Company left its Viatris share count unchanged in Q2 2026.
  • Viatris made up 0.01% of Barrett & Company's portfolio in Q2 2026, its #439 holding.
  • Barrett & Company first reported a position in Viatris in Q3 2022 and has held it in 16 quarters since.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.